Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
Aakash Desai
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
Justin F. Gainor
Department of Hematology and Oncology, O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
Aparna Hegde
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Alison M. Schram
Department of Oncology and Hemato- Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy
Giuseppe Curigliano
Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Sumanta Pal
Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
Stephen V. Liu
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA
Balazs Halmos
Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
Roman Groisberg
Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain
Enrique Grande
Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA
Tomislav Dragovich
Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA
Marc Matrana
Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
Neeraj Agarwal
Sarcoma Oncology Center, Santa Monia, CA, USA
Sant Chawla
Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA
Shumei Kato
Department of Oncology, Skåne University Hospital, Lund, Sweden
Gilberto Morgan
Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA
Pashtoon M. Kasi
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Benjamin Solomon
Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China
Herbert H. Loong
Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA
Haeseong Park
Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA, USA
Toni K. Choueiri
Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ishwaria M. Subbiah
Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Naveen Pemmaraju
Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vivek Subbiah
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vivek Subbiah
MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vivek Subbiah
